News | August 30, 2025
MHRA approves UK’s first new type of antibiotic for urinary tract infections
As with any medicine, the MHRA will keep the safety of gepotidacin under close review
As with any medicine, the MHRA will keep the safety of gepotidacin under close review
The new facility will enhance AbbVie’s chemical synthesis capacity to support domestic production of current and next-generation neuroscience, immunology, and oncology medicines
EBITDA stood at Rs. 100.1 crore with a margin of 16.1 per cent
These filings come after FDA issued its latest warning to patients and healthcare professionals about the serious dangers of compounded GLP-1 drugs
EBITDA rose to Rs. 218.1 crore, a 14.8% year-on-year increase
The companies will now begin detailed contract negotiations and proceed with necessary consultations and approval processes
Elevidys is currently the only approved gene therapy that targets the root cause of Duchenne
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
Singhal brings a powerful blend of operational excellence, investor acumen, and visionary thinking
The phase III ARNASA study did not meet the primary endpoint of a statistically significant reduction in the AER at 52 weeks
Subscribe To Our Newsletter & Stay Updated
